Supplementary Table 1 from Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
Year: 2023
Type: supplementary-materials
Abstract: PDF - 59KB, Frequency of immune-related adverse events (irAEs) in the present study and in a previous study.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362628069